MedTech Strategist Issue: Vol. 5, No. 17 - December 19, 2018

 

Already a Subscriber?

 

Not a Subscriber?


Surgical Robotics - “Intuitive Surgical: As Robotics Heats Up, Can the Market Leader Stay Ahead of the Pack?”

By David Cassak, Co-Editor-in-Chief

Intuitive Surgical pioneered robotically-enabled surgery and for years largely had the field to itself, in the process building one of the most successful medtech companies ever. But now, as the company nears its 25th anniversary, robotics is facing major changes, with both increased competition and the incorporation of advanced analytics. Can this long-time leader stay ahead of the game? Part 1 of a 2-part feature.

ISRG.jpg

kyler-trautner-693525-unsplash.jpg

Perspective - “Medtech vs. Pharma: Will Digital Bridge the Culture Gap?”

By Melanie Senior, Contributing Writer

Medtech and pharma have long stood on opposite sides of a culture divide. Talk of drug-device convergence has, mostly, remained just that. But digital technology is now bridging the gap, creating new treatment modalities where data, not tools or drugs, are king.


Venture Capital - “Portfolia’s FemTech Fund Activates a New Source of Investors: Women”

Sidebar: “Joylux: Dialogue—and a Giant Market—Open Up Around a Problem Women Didn’t Admit they Had”

By Mary Stuart, Senior Writer/Market Analyst

Portfolia’s model of investing is designed for a new generation of female investors. It combines the engagement of Angel investing with the professional management of venture capital.

FemTech.jpg

Infectious Disease Diagnostics - “Next-Gen Technologies Aim to Reform the Microbiology Lab, But Do They Pose Significant Threats to the Big Guys?”

By Wendy Diller, Senior Writer/Market Analyst

Many young companies are working on new approaches to improving infectious disease testing, almost all with an eye toward some of medicine’s most incalcitrant challenges: earlier diagnosis of sepsis and faster susceptibility testing.  Several new promising options are available, but so far, none of these is comprehensive and it remains to be seen whether any will be threats to entrenched large companies.


M&A/Financing Review - “Financing Reversal of Fortune As IPOs Out-Pace M&A”

By Stephen Levin, Co-Editor-in-Chief

After several years of waiting for the public market to re-open, medtech IPOs continue to remain healthy, while M&A deal numbers turn flat and valuations drop.


Adagio Medical.png

Atrial Fibrillation - “Adagio Medical: Lowering Temperatures, Raising Bars”

By Colin Miller, Contributing Writer

Co-founded by a renowned heart surgeon, Adagio Medical reexamines the key success factors of cardiac ablation for atrial fibrillation and offers a solution for some of its most vexing challenges. Adagio’s iCLAS system and OneShot+ catheter enable faster, more effective cryoablation than today’s balloon-assisted methods by using proprietary Near-Critical Nitrogen technology.


Women’s Health - “Madorra: A New, Non-hormonal, Noninvasive Solution for Vaginal Tissue Health”

By Mary Stuart, Senior Writer/Market Analyst

When queried, women asked for a non-hormonal solution to vaginal dryness that could be used in the home. They preferred a noninvasive therapy that would be discreet, easy to use, and would not need to be inserted into the vaginal canal. Women’s health company Madorra Medical is well on its way to granting their wishes.

Madderra.png

Not a Subscriber?

Already a Subscriber?

Want a Sample Article?


Companies Covered in this Issue: Accelerate Diagnostics Inc., Adagio Medical Inc., Allergan PLC, Alma Lasers, Alphabet Inc., Amazon.com Inc., Amgen Inc., Apellis Pharmaceuticals, Apple Inc., Beckman Coulter Inc.,   Becton Dickinson & Co., bioMerieux Inc., Boston Scientific Corp., ChromaCode Inc., CMR Surgical Ltd., Corindus Vascular Robotics Inc., Curetis NV, Day Zero Diagnostics Inc., DexCom Inc., DistalMotion SA,  Enable Injections Inc., Establishment Lab Holdings Inc., First Light Biosciences, Flex Digital Health, Flex Ltd., Fotona, Fresenius Medical Care AG & Co. KGAA, Future Family, Galen Robotics Inc., GlaxoSmithKline PLC, Glooko, Google, Hill-Rom Holdings Inc., Hologic Inc., IBM Watson Health, Immunexpress Inc., InMode Aesthetic Solutions, Inflammatix Inc., Inspire Medical Systems Inc.,  Intuitive Surgical Inc., Johnson & Johnson, Joylux Inc., Karius Inc., Luminex Corp., Madorra Medical, Magnolia Medical Technologies Medical Microinstruments SPA, Medtronic PLC, Novartis AG, Novo Nordisk AS, OpGen Inc., Otsuka Pharmaceutical Co. Ltd., Panasonic, Pear Therapeutics Inc., Predigen Inc., Proteus Digital Health, Qiagen NV, Qvella Corp., RoboCath Inc., Roche, Sandstone Diagnostics Inc., Sanofi, Sony, Stryker Corp., T2 Biosystems Inc.  Thermo Fisher Scientific Inc., TransEnterix Inc., UCB SA, Venus Concept Medical Aesthet­ics, Verb Surgical Inc., Verily Life Sciences, Viveve Medical Inc., Wright Medical Group NV, Zoetis Inc.

Topics Covered in this Issue: Business Strategies; Cardiovascular/Vascular; Critical Care/Emergency Medicine; Diagnostics; Digital Health; Investors & Dealmaking; Perspective & Commentary; Start-Ups; Surgery/Robotics; Urology/Renal; Women’s Health